arrow
H

Hossein Ardeschir Ghofrani

German Center for Lung Research
H指数:120
被引数:8.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

RETRACTED: Sydykov et al. Genetic Deficiency and Pharmacological Stabilization of Mast Cells Ameliorate Pressure Overload-Induced Maladaptive Right Ventricular Remodeling in Mice. Int. J. Mol. Sci. 2020, 21, 9099

撤稿:Sydykov等人。遗传缺陷和药理学稳定肥大细胞可改善压力过载诱导的小鼠不良性右心室重塑。Int. J. Mol. Sci. 2020, 21, 9099

2026-09-290
OA
Results of the MACiTEPH study of macitentan for the treatment of inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension

MACiTEPH研究的麦卡替尼治疗不可手术或持续/复发性慢性血栓栓塞性肺动脉高压的结果

2025-11-240
PRE
Survival in patients with chronic thromboembolic pulmonary hypertension treated with riociguat versus other medications: a COMPERA analysis
2025-11-031
PRE
Add-On Therapy with Parenteral Prostacyclin Analogues in Patients with Pulmonary Arterial Hypertension: Insights from the COMPERA Registry

静脉注射前列环素类似物作为附加疗法在肺动脉高压患者中的应用:COMPERA登记研究的见解

2025-10-240
OAAI
Pulmonary Hypertension Associated with Lung Diseases

与肺部疾病相关的肺动脉高压

2025-10-010
PRE
Living human lung slices for ex vivo modelling of lung cancer

活体人肺切片用于体外肺癌建模

2025-09-091
OA
Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis

sotatercept 用于诊断后第一年的肺动脉高压

2025-09-012
PRE
Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study

Seralutinib治疗成人肺动脉高压:TORREY开放标签扩展研究

2025-08-110
OA
Exercise haemodynamics in pulmonary hypertension – a prospective pressure–volume loop study on right ventricular adaptation and prognosis

运动血流动力学在肺动脉高压中的作用——一项关于右心室适应和预后的前瞻性压力-容积环研究

2025-08-070
OAAI
Transcriptional changes of the extracellular matrix in chronic thromboembolic pulmonary hypertension govern right ventricle remodeling and recovery

细胞外基质转录变化在慢性血栓栓塞性肺动脉高压中调控右心室重塑与恢复

2025-07-040
OAAI
Corrigendum to ‘‘Safety and efficacy of riociguat in patients with pulmonary arterial hypertension and cardiometabolic comorbidities: Data from interventional clinical trials’’ [The Journal of Heart and Lung Transplantation, 44 (2025) 135–146]

更正:关于“在肺动脉高压合并心血管代谢共病患者中 riociguat 的安全性与有效性:来自干预性临床试验的数据”[《心肺移植杂志》,44(2025)135–146]

2025-04-090
OAAI
Mono and combination therapies in pulmonary arterial hypertension patients with comorbidities: A COMPERA analysis
2025-03-010
OAAI
Safety and efficacy of riociguat in patients with pulmonary arterial hypertension and cardiometabolic comorbidities: Data from interventional clinical trials

riociguat在肺动脉高压和心脏代谢合并症患者中的安全性和有效性: 来自干预性临床试验的数据

2025-02-011
PRE